top of page

Genesis Healthcare Co. Announces the Release of GenesisGaia Beauty

A Genomic Data Platform Dedicated to Skincare and Cosmetics R&D

Tokyo, February 5, 2024 – GenesisGaia, a pioneering generative A.I. platform powered by genomic big data for Life Sciences, is extending its services to the skincare and cosmetics industry.

The life science and pharmaceutical industries have leveraged large-scale genetic based R&D and genomic data to support their drug discoveries. The skincare and cosmetics industries are adopting similar R&D approaches to identify key pathways involved in skin aging and other skincare conditions.


Genesis Healthcare releases GenesisGaia Beauty, a genomic platform dedicated to skincare and cosmetics R&D and product development.

Taking the guesswork out of the skincare equation, GenesisGaia Beauty supports researchers in identifying molecular and genomic correlations between cosmetic ingredients, genes, and their effect(s) in the skin.

Based on data generated from cosmetic ingredients and epithelial cells with RNA sequencing, GenesisGaia Beauty empowers researchers by visualizing the predicted correlation(s) between skincare/cosmetics ingredients and skin genes.

Using a network diagram tool to indicate positive and negative correlations as well as their strengths, GenesisGaia Beauty supports researchers with an intuitive platform to identify associations, relationships, and potential effects of cosmetic ingredients and genes on the skin.

Within the platform, filtering functions are available to narrow down inquiries of interest and include all relevant supporting literature.


GenesisGaia Beauty offers modular services to customize its platform to the specific needs and requirements of researchers, including the addition of new data sets, import of own and third-party databases as well as tailored analytical services, algorithms, A.I. and machine learning-based models, and more.


With the largest genomic R&D database for the Japanese population, GenesisGaia Beauty features an extensive range of genomic and phenotypic data sets relevant to skincare and cosmetics R&D.

With more than 340,000 curated microarray genomes, researchers can select relevant genes to validate their R&D initiatives and tailor new products specifically to the Japanese population. The range of data sets is extensive, covering multiple genes linked to skin aging, pigmentation, formation of wrinkles, freckles or spots, effects of UVs or antioxidants, atopic dermatitis, and much more.

Offering case and control options to researchers, GenesisGaia Beauty supports the development of customized cohort studies through opt-in and re-contactable participants.


In addition, GenesisGaia Beauty features hair-related data sets such as hair morphology, alopecia areata, androgenetic alopecia and others.

For press and media inquiries, please contact:


About Genesis Healthcare Co. 

Celebrating its 20th anniversary, Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.


For additional information, please visit:


GenesisGaia is a registered trademark of Genesis Healthcare Co.



bottom of page